The 10 analysts offering 12-month price forecasts for Gossamer Bio Inc have a median target of 18.00, with a high estimate of 21.00 and a low estimate of 12.00. The median estimate represents a +27.12% increase from the last price of 14.16.
The current consensus among 10 polled investment analysts is to Buy stock in Gossamer Bio Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.65
Reporting Date Nov 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.